Scienta’s new AI model targets aging-linked inflammation
Scienta Lab launched EVA, a multimodal AI model that integrates gene, tissue and protein data to predict drug candidate performance in immunology and aging-linked inflammation, reporting up to twofold improved benchmarks versus existing models to better prioritize translational targets.
Why it mattersEVA's doubled prediction accuracy for drug targets lets R&D teams prioritize fewer candidates, reducing trial costs.